Bettina Bannert

1.8k total citations
13 papers, 158 citations indexed

About

Bettina Bannert is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bettina Bannert has authored 13 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 3 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Bettina Bannert's work include Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Salivary Gland Disorders and Functions (2 papers). Bettina Bannert is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Salivary Gland Disorders and Functions (2 papers). Bettina Bannert collaborates with scholars based in Switzerland, Germany and United States. Bettina Bannert's co-authors include Diego Kyburz, Reinhard Voll, Mirjam Kunze, Jens Thiel, Julian Staniek, Miriam Erlacher, Kathleen E. Fischer, Arianna Troilo, Nils Venhoff and Raquel Lorenzetti and has published in prestigious journals such as PLoS Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Bettina Bannert

12 papers receiving 153 citations

Peers

Bettina Bannert
Suguru Honda Japan
Noriyuki Yamakawa Japan
Fabio De Gennaro Italy
Yoko Miura Japan
À. Olivé Spain
William Murray‐Brown Australia
Yoshino Inoue Japan
Gianfranco Vitiello Italy
V. Varisco Italy
Izumi Kurata Japan
Suguru Honda Japan
Bettina Bannert
Citations per year, relative to Bettina Bannert Bettina Bannert (= 1×) peers Suguru Honda

Countries citing papers authored by Bettina Bannert

Since Specialization
Citations

This map shows the geographic impact of Bettina Bannert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Bannert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Bannert more than expected).

Fields of papers citing papers by Bettina Bannert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Bannert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Bannert. The network helps show where Bettina Bannert may publish in the future.

Co-authorship network of co-authors of Bettina Bannert

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Bannert. A scholar is included among the top collaborators of Bettina Bannert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Bannert. Bettina Bannert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bellwald, Sebastian, Bettina Bannert, Marie Roumet, et al.. (2025). Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial). PLoS Medicine. 22(5). e1004472–e1004472. 2 indexed citations
2.
Alten, Rieke, Hans‐Peter Tony, Bettina Bannert, et al.. (2023). Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus. Clinical Rheumatology. 42(9). 2321–2334. 1 indexed citations
3.
Alten, Rieke, Xavier Mariette, René‐Marc Flipo, et al.. (2022). Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study. Clinical Rheumatology. 41(8). 2361–2373. 14 indexed citations
4.
Schmitt, Christophe, Laura Brockwell, Mauro Zucchetto, et al.. (2022). Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study. Arthritis Research & Therapy. 24(1). 133–133. 9 indexed citations
5.
Alten, Rieke, Xavier Mariette, René‐Marc Flipo, et al.. (2021). OP0180 IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA. Annals of the Rheumatic Diseases. 80. 108–108.
6.
Dumusc, Alexandre, et al.. (2020). Use of a smart lip holder for minimally invasive minor salivary gland biopsy. BMJ Innovations. 7(2). 445–447. 2 indexed citations
7.
Daoudlarian, Douglas, Michel Theron, Fabrice A. Kolb, et al.. (2019). Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome. Arthritis Research & Therapy. 21(1). 175–175. 25 indexed citations
8.
Bühler, Silja, Veronika K. Jaeger, Sabine Adler, et al.. (2019). Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study. Lara D. Veeken. 58(9). 1585–1596. 20 indexed citations
9.
Deiseroth, Arne, Thimo Marcin, Denis Infanger, et al.. (2018). Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities. Frontiers in Physiology. 9. 8 indexed citations
10.
Galeazzi, M., Gian Domenico Sebastiani, Reinhard Voll, et al.. (2017). OP0099 Safety, tolerability and initial signs of efficacy of the fully human immunocytokine DEKAVIL (F8IL10): a novel therapeutic approach for rheumatoid arthritis. Annals of the Rheumatic Diseases. 76. 92–93. 2 indexed citations
11.
Rizzi, Marta, Raquel Lorenzetti, Kathleen E. Fischer, et al.. (2016). Impact of tofacitinib treatment on human B-cells in vitro and in vivo. Journal of Autoimmunity. 77. 55–66. 52 indexed citations
12.
Kollert, Florian, Stephan Budweiser, Bettina Bannert, et al.. (2012). Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis. Arthritis Care & Research. 65(2). 281–287. 18 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suguru Honda Breakdown of academic impact, for papers by Noriyuki Yamakawa Breakdown of academic impact, for papers by Fabio De Gennaro Breakdown of academic impact, for papers by Yoko Miura Breakdown of academic impact, for papers by À. Olivé Breakdown of academic impact, for papers by William Murray‐Brown Breakdown of academic impact, for papers by Yoshino Inoue Breakdown of academic impact, for papers by Gianfranco Vitiello Breakdown of academic impact, for papers by V. Varisco Breakdown of academic impact, for papers by Izumi Kurata
Rankless by CCL
2026